1cP-LSD Micro Pellets – 10mcg
€ 10,00 – € 100,00Price range: € 10,00 through € 100,00
1cP-LSD Micro Pellets are described as compressed research units associated with 1-cyclopropanoyl-LSD, an N1-acylated derivative of lysergic acid diethylamide.
The named compound belongs to the lysergamide family and is structurally distinguished from LSD by a cyclopropanoyl substituent at the indole nitrogen.
The supplied source identifies a compact pellet-format preparation with a labeled analyte quantity, intended for controlled analytical and non-clinical laboratory research.
Relevant scientific contexts include chemical identification, chromatographic characterization, analytical method development, and comparative investigation of related lysergamide structures.
The source refers to HPLC verification, batch identification, and Certificate of Analysis documentation where applicable.
However, no actual batch-specific analytical report or supporting certificate was supplied.
The finished-unit analyte content, content uniformity, ingredient purity, excipient composition, and chemical form remain unverified.
The pellets are not established as certified reference materials or validated quantitative calibration standards.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
1cP-LSD Micro Pellets 10mcg – Lysergamide Research Material
Product Overview
1cP-LSD Micro Pellets are described as compressed research units associated with 1-cyclopropanoyl-LSD, an acylated derivative of lysergic acid diethylamide.
The named compound belongs to the lysergamide family.
Its molecular structure differs from LSD through the presence of a cyclopropanoyl substituent at the indole nitrogen.
The supplied source presents the product as a compact pellet-format preparation intended for controlled analytical and non-clinical laboratory research.
The source identifies a labeled analyte quantity per micro pellet.
However, no actual finished-unit assay or content-uniformity report accompanied the information.
The labeled analyte quantity therefore remains a source-provided specification rather than an independently verified analytical result.
The supplied material describes scientific interest in chemical identity, structural comparison, and analytical characterization of lysergamides.
These contexts should be distinguished from claims about the actual finished pellets.
No batch-specific identity certificate, impurity profile, or validated assay result was supplied.
The source also refers to HPLC verification, batch identification, and Certificate of Analysis documentation where applicable.
These statements remain unverified without supporting records.
The finished preparation is not established as a certified reference material, validated quantitative calibrator, or approved pharmaceutical product.
Chemical Identity & Classification
The supplied source identifies 1cP-LSD as a lysergamide research compound.
The commonly used chemical designation is 1-cyclopropanoyl-LSD.
The cyclopropanoyl substituent distinguishes the named compound structurally from LSD and other N1-acylated lysergamides.
The supplied product information includes:
- Common designation: 1cP-LSD
- Descriptive chemical name: 1-Cyclopropanoyl-LSD
- Chemical classification: N1-acylated lysergamide
- Reported presentation: Compressed micro pellets
- Labeled analyte amount: Specified per finished pellet
- Intended designation: Research Use Only
The current source does not independently document the CAS Registry Number, molecular formula, molecular weight, salt form, or stereochemical composition of the actual batch.
Those details should be confirmed against authoritative chemical-reference information and batch-specific analytical documentation before publication as verified specifications.
The molecular structure of a named compound does not establish the composition of a finished pellet preparation.
Additional formulation components may be present, but the source does not identify them.
Researchers may consult PubChem for public chemical-reference information, ensuring that any selected database entry corresponds to the actual chemical form and stereochemical designation being examined.
Chemical & Physical Characteristics
The supplied source describes the product as compact micro pellets.
A compressed pellet is a finished preparation in which the named analyte may be combined with other formulation components.
The characteristics of the complete preparation therefore differ from those of the isolated compound.
The source does not identify the excipient composition, pellet dimensions, total unit mass, manufacturing method, or surface characteristics.
No actual product-specific physical inspection report or finished-unit composition record was supplied.
The named compound contains a cyclopropanoyl substituent attached to the lysergamide framework.
This structural feature distinguishes 1cP-LSD from LSD and from related derivatives containing different substituents.
However, structural classification alone does not establish the physicochemical characteristics of the actual pellet preparation.
The source does not provide experimentally verified solubility measurements, melting-point data, degradation profiles, or complete physical characterization.
It also does not establish the distribution of analyte throughout the compressed formulation.
Consequently, the properties of the isolated compound should not be assumed to describe the complete finished unit.
The source recommends cool, dry storage protected from light.
No validated product-specific stability study accompanied that recommendation.
Purity & Analytical Verification
The supplied source refers to HPLC-verified purity where applicable.
However, no actual batch-specific Certificate of Analysis or laboratory report accompanied that statement.
No chromatogram, mass spectrum, NMR spectrum, impurity profile, or independent laboratory certificate was supplied.
Accordingly, no specific purity result can be confirmed for the actual product batch.
For micro-pellet preparations, the chemical purity of the named ingredient and the actual analyte quantity in each finished unit are separate analytical characteristics.
An ingredient-purity result does not independently establish finished-unit content or content uniformity.
The source also does not establish whether any claimed purity measurement applies to isolated bulk material or the complete finished preparation.
The source describes the material in reference-oriented research terms.
However, no certified reference-material documentation, assigned measurement value, uncertainty statement, or metrological traceability record was supplied.
The finished pellets should therefore not be represented as certified quantitative reference standards.
Any definitive analytical claims require actual supporting batch records.
Quality Control & Batch Integrity
The supplied source refers to batch identification, analytical verification, and Certificate of Analysis documentation.
These statements describe proposed or claimed quality-assurance practices.
No actual certificate, independent testing report, manufacturing audit, or batch-specific quality-control record accompanied the information.
They therefore remain unverified supplier claims.
For reproducible analytical documentation, relevant records may include verified chemical identifiers, confirmed stereochemical composition where available, batch number, analytical findings, receipt date, and available storage history.
For compressed preparations, the identity and purity of the named compound should be distinguished from the composition and consistency of the finished units.
The supplied information does not establish independently verified analyte content, excipient composition, or content uniformity.
The source also does not provide evidence that every finished micro pellet meets a particular quantitative specification.
The Research Use Only designation describes intended positioning but does not independently demonstrate manufacturing quality or analytical traceability.
Claims concerning batch consistency and validated analytical performance should be supported by actual records.
Safety, Handling & Laboratory Precautions
1cP-LSD is a synthetic lysergamide associated with significant pharmacological activity and potential toxicological uncertainty.
The supplied source does not provide a complete product-specific toxicological assessment.
Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.
Relevant precautions include restricted access, appropriate protective equipment, contamination prevention, accidental-exposure procedures, and chemical-waste management.
The micro-pellet presentation does not establish safety for human or veterinary exposure.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.
Because the actual chemical form, ingredient purity, excipient composition, and finished-unit content have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.
Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.
Packaging, Labeling & Storage
The supplied source describes discreet packaging, careful handling, tracking, and batch labeling.
No actual packaging specification, container-validation report, or shipment-condition record was provided.
The source recommends storage in a tightly sealed container in a cool, dry environment protected from light.
No validated product-specific stability study was supplied to establish a particular storage temperature or shelf life.
Laboratory inventory records should preserve the product designation, any available batch identifier, receipt details, and relevant storage observations.
The labeled analyte quantity should be recorded as a source-provided specification unless independently verified.
Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional procedures.
Intended Research Use & Market Positioning
The supplied scientific context places 1cP-LSD within analytical research involving lysergamide chemical identity, structural comparison, and laboratory method development.
The cyclopropanoyl substituent provides a distinguishing structural feature relevant to chemical characterization.
The source also describes interest in stability-focused investigations and comparative analytical workflows.
However, no product-specific analytical validation or stability dataset was supplied for the actual micro pellets.
The supplied Raw Lab Chems catalog includes 1cP-LSD Micro Pellets, corresponding to the listing discussed here.
For comparative product-format context, Raw Lab Chems also lists 1cP-LSD Pellets and 1D-LSD Blotters.
The second listing refers to the same named compound with a different labeled strength.
The 1D-LSD listing refers to a structurally related but chemically distinct lysergamide.
These products should not be treated as chemically identical or analytically interchangeable.
The supplied information does not establish equivalent chemical purity, analyte content, excipient composition, or content uniformity across the preparations.
These catalog references should not be interpreted as evidence of certified reference-material status or validated quantitative equivalence.
Ordering, Availability & Fulfillment
The supplied source describes protective packaging, international shipping, tracking, and secure handling arrangements.
No current inventory record, carrier agreement, shipment authorization, or verified delivery information was supplied.
Consequently, no availability, delivery-time, customs-clearance, or transportation-compliance guarantee is asserted.
1cP-LSD may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.
Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.
Research-only labeling does not establish a legal exemption.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
1cP-LSD is a synthetic lysergamide whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.
The supplied information does not establish universal legal status or regulatory authorization.
Institutions remain responsible for determining applicable legal requirements and obtaining any necessary permissions.
No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.
| Quantity (pellets) |
5 ,10 ,25 ,50 ,100 |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.